Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
Double TKI Therapy Improves Responses in MET Amplification-Driven EGFR-Mutant Non-Small Cell Lung Cancer
Double TKI Therapy Improves Responses in MET Amplification-Driven EGFR-Mutant Non-Small Cell Lung Cancer
Author
Oncology Times
Published
Thu 16 Nov 2023
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/OT-POD_EP48_11082023.mp3
Share to:
